Therapeutic effect of probiotics and oral IgY as supplementary drugs in the treatment of  pediatric rotavirus enteritis: a comparative study

XIE Yong-Mei; GAO Shan; WANG Li-Yuan; WANG Zhi-Ling

doi:10.7499/j.issn.1008-8830.2013.11.018

PDF(1520 KB)

Chinese Journal of Contemporary Pediatrics ›› 2013, Vol. 15 ›› Issue (11) : 1000-1005. DOI: 10.7499/j.issn.1008-8830.2013.11.018

CLINICAL RESEARCH

Therapeutic effect of probiotics and oral IgY as supplementary drugs in the treatment of pediatric rotavirus enteritis: a comparative study

XIE Yong-Mei, GAO Shan, WANG Li-Yuan, WANG Zhi-Ling

Author information +

History +

Abstract

OBJECTIVE: To compare the therapeutic effect of probiotics and oral immunoglobulin on pediatric rotavirus enteritis. METHODS: A randomized, controlled trial was conducted in 150 children with rotavirus enteritis who were randomly divided into control, probiotic and immunoglobulin groups (n=50 each). In addition to basic treatment, the control group was given placebo, the probiotic group was given live combined bifidobacterium and lactobacillus tablets, and the immunoglobulin group was orally given anti-rotavirus egg yolk immunoglobulin (IgY). Clinical symptoms such as stool frequency and stool properties were recorded every day. Fresh stool samples were collected on days 1, 3, 5, 7, 9 and 11 of treatment. Intestinal flora imbalance was detected and divided into three degrees by microscopic examination of stool. Fecal SIgA level and fecal rotavirus shedding were measured by radioimmunoassay and double-antibody sandwich ELISA respectively. RESULTS: Compared with the control group, the probiotic group had reduced intestinal flora imbalance, decreased stool frequency, and reduced incidence of secondary intestinal bacterial infection after 3 days of treatment (P<0.05). There was no significant difference in disease course between the probiotic and control groups. Compared with the control group, the immunoglobulin group had a significantly increased fecal SIgA level after 1 day of treatment (P<0.05), significantly decreased frequency of diarrhea and fecal rotavirus shedding after 3 days of treatment (P<0.05), and a significantly shorter disease course (4.5±1.0 vs 5.8±1.7 days; P<0.05). CONCLUSIONS: For children with rotavirus enteritis, probiotics can reduce intestinal flora imbalance and prevent secondary intestinal bacterial infection, but probiotics take a long time to relieve clinical symptoms and cannot shorten the course of disease. Oral immunoglobulin takes effect quickly and can rapidly eliminate rotavirus, promote the production of SIgA, and shorten the course of disease.

Key words

Rotavirus / Probiotics / Immunoglobulin / Randomized controlled trial / Child

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

XIE Yong-Mei, GAO Shan, WANG Li-Yuan, WANG Zhi-Ling. Therapeutic effect of probiotics and oral IgY as supplementary drugs in the treatment of pediatric rotavirus enteritis: a comparative study[J]. Chinese Journal of Contemporary Pediatrics. 2013, 15(11): 1000-1005 https://doi.org/10.7499/j.issn.1008-8830.2013.11.018

References

[1] Mattei A, Angelone AM, Michetti M, Sbarbati M, Ceci R, Murgano A, et al. Epidemiological impact of RV gastroenteritis in the Abruzzo Region: SDO analysis [J]. Ann Ig, 2009, 21(1): 41-49.

[2] Palumbo E, Malorgio C, Siani A, Bonora G. Diarrhoea in children: aetiology and clinical aspects [J]. Infez Med, 2009, 17(2): 95-99.

[3] 张春芳, 贾立英. 亚洲地区轮状病毒感染的流行病学概况 [J]. 中国当代儿科杂志, 2006, 8(1): 79-82.

[4] Goveia MG, Nelson CB, Ciarlet M. RotaTeq: Progress toward developing world access[J]. J Infect Dis, 2010, 202(Suppl): S87-S92.

[5] O'Ryan M, Lucero Y, O'Ryan-Soriano MA, Ashkenazi S. An update on management of severe acute infectious gastroenteritis in children [J]. Expert Rev Anti Infect Ther, 2010, 8(6): 671-682.

[6] 张秀荣, 狳智民. 肠道菌群粪便涂片检查图谱 [M]. 北京: 人民军医出版社, 2000: 1-23．

[7] Fang SB, Lee HC, Hu JJ, Hou SY, Liu HL, Fang HW. Dose-dependent effect of Lactobacillus rhamnosus on quantitative reduction of faecal rotavirus shedding in children [J]. J Trop Pediatr, 2009, 55(5): 297-301.

[8] Mao M, Yu T, Xiong Y, Wang Z, Liu H, Gotteland M, et al. Effect of a lactose-free milk formula supplemented with bifidobacteria and streptococci on the recovery from acute diarrhoea [J]. Asia Pac J Clin Nutr, 2008, 17(1): 30-34.

[9] 韦立功.婴幼儿轮状病毒肠炎的药物治疗现状 [J].中国当代儿科杂志, 2001, 3(2): 207-209.

[10] 张琳, 丘学淑，李素娥. 婴幼儿轮状病毒肠炎肠道菌群的动态变化 [J]. 中华儿科杂志, 1994, 32(5):282-284.

[11] Ciftci E, Tapisiz A, Ozdemir H, Güriz H, Kendirli T, Ince E, et al. Bacteraemia and candidaemia: a considerable and underestimated complication of severe rotavirus gastroenteritis [J]. Scand J Infect Dis, 2009, 41(11-12): 857-861.

[12] Guandalini S, Pensabene L, Zikri MA, Dias JA, Casali LG, Hoekstra H, et al. Lactobacillus GG administered in oral rehydration solution to children with acute diarrhea: a multicenter European trial [J]. J Pediatr Gastroenterol Nutr, 2000, 30(1): 54-60.

[13] Tabbers MM, Benninga MA. Administration of probiotic lactobacilli to children with gastrointestinal problems: there is still little evidence [J]. Ned Tijdschr Geneeskd, 2007, 151(40): 2198-2202.

[14] Rosenfeldt V, Michaelsen KF, Jakobsen M, Larsen CN, Moller PL, Tvede M, et al. Effect of probiotic Lactobacillus strains on acute diarrhea in a cohort of nonhospitalized children attending day-care centers [J]. Pediatr Infect Dis J, 2002, 21(5): 417-419.

[15] Basu S, Paul DK, Ganguly S, Chatterjee M, Chandra PK. Efficacy of high-dose Lactobacillus rhamnosus GG in controlling acute watery diarrhea in Indian children: a randomized controlled trial [J]. J Clin Gastroenterol, 2009, 43(3): 208-213.

[16] Gonzalez AM, Azevedo MS, Jung K, Vlasova A, Zhang W, Saif LJ. Innate immune responses to human rotavirus in the neonatal gnotobiotic piglet disease model [J]. Immunology, 2010, 131(2): 242-256.

[17] Corthesy B, Benureau Y, Perrier C, Fourgeux C, Parez N, Greenberg H, et al. Rotavirus anti-VP6 secretory immunoglobulin A contributes to protection via intracellular neutralization but not via immune exclusion [J]. J Virol, 2006, 80(21): 10692-10699.

[18] Burns JW, Siadat-Pajouh M, Krishnaney AA, Greenberg HB. Protective effect of rotavirus VP6-specific IgA monoclonal antibodies that lack neutralizing activity [J]. Science, 1996, 272(5258): 104-107.

[19] Sarker SA, Pant N, Juneja LR, Hammarstrom L. Successful treatment of rotavirus-induced diarrhoea in suckling mice with egg yolk immunoglobulin [J]. J Health Popul Nutr, 2007, 25(4): 465-468.

[20] Sarker SA, Casswall TH, Juneja LR, Hoq E, Hossain I, Fuchs GJ, et al. Randomized, placebo-controlled, clinical trial of hyperimmunized chicken egg yolk immunoglobulin in children with rotavirus diarrhea [J]. J Pediatr Gastroenterol Nutr, 2001, 32(1):19-25.

[21] 童新国. 口服丙种球蛋白治疗轮状病毒腹泻 [J]. 中国当代儿科杂志, 1999, 1(2): 92-93.

[22] Ruggeri FM, Johansen K, Basile G, Kraehenbuhl JP, Svensson L. Antirotavirus immunoglobulin A neutralizes virus in vitro after transcytosis through epithelial cells and protects infant mice from diarrhea [J]. J Virol, 1998, 72(4): 2708-2714.

[23] Hennewig U, Schulz A, Adams O, Friedrich W, Gobel U, Niehues T. Severe combined immunodeficiency signalized by eosinophilia and lymphopenia in rotavirus infected infants [J]. Klin Padiatr, 2007, 219(6): 343-347.

[24] Sato A, Iizuka M, Nakagomi O, Suzuki M, Horie Y, Konno S, et al. Rotavirus double-stranded RNA induces apoptosis and diminishes wound repair in rat intestinal epithelial cells [J]. J Gastroenterol Hepatol, 2006, 21(3): 521-530.